Skip to content
lifestyle.militaryparenting.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Lupin Pharmaceutical, Inc.
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
September 28, 2026
Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
September 4, 2026
Lupin Announces Approval from U.S. FDA for Pitolisant Tablets
August 21, 2026
Lupin Announces the Approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
August 20, 2026
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
August 19, 2026
Lupin Announces the Approval of Diazepam Injection, USP in the United States
August 18, 2026
Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy
July 21, 2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
June 26, 2026
Lupin Launches Azilsartan Medoxomil Tablets in the United States
June 17, 2026
Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
June 4, 2026